cobas® SARS-CoV-2 Qualitative for use on the cobas® 5800/6800/8800 Systems
Roche Molecular Systems, Inc. · Microbiology
Open FDA's page for this record- Third party flag
- N
- City
- Pleasanton
- Advisory committee description
- Microbiology
- Address 1
- 4300 Hacienda Dr.
- Statement or summary
- Summary
- Product code
- QQX
- Zip code
- 94028
- Applicant
- Roche Molecular Systems, Inc.
- Decision date
- 2025-02-11
- Decision code
- SESE
- Country code
- US
- Device name
- cobas® SARS-CoV-2 Qualitative for use on the cobas® 5800/6800/8800 Systems
- Advisory committee
- MI
- Contact
- Mounika Kommineni
- K number
- K240867
- State
- CA
- Date received
- 2024-03-29
- Review advisory committee
- MI
- Postal code
- 94028
- Decision description
- Substantially Equivalent
- Clearance type
- Traditional
- Harmonized identifiers (openFDA)
- Device name
- Respiratory Specimen Nucleic Acid Sars-Cov-2 Test
- Medical specialty description
- Microbiology
- Regulation number
- 866.3981
- Device class
- 2
- Registration number
- 3009976420, 3021140368, 3004530258, 2024800, 3007420875, 2243471, 3006247421, 3016838963, 1119779, 3009613136, 3010770794, 3004141078
- FEI number
- 3009976420, 3021140368, 3004530258, 2024800, 3007420875, 2243471, 3006247421, 3016838963, 1119779, 3009613136, 3010770794, 3004141078
